.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020913

« Back to Dashboard
NDA 020913 describes AGGRASTAT, which is a drug marketed by Medicure and is included in two NDAs. It is available from one supplier. There are six patents protecting this drug. Additional details are available on the AGGRASTAT profile page.

The generic ingredient in AGGRASTAT is tirofiban hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the tirofiban hydrochloride profile page.

Summary for NDA: 020913

Tradename:
AGGRASTAT
Applicant:
Medicure
Ingredient:
tirofiban hydrochloride
Patents:6
Formulation / Manufacturing:see details

Pharmacology for NDA: 020913

Physiological EffectDecreased Platelet Aggregation

Suppliers and Packaging for NDA: 020913

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION 020913 NDA Medicure International Inc 25208-002 25208-002-01 1 CONTAINER in 1 CARTON (25208-002-01) > 100 mL in 1 CONTAINER
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION 020913 NDA Medicure International Inc 25208-002 25208-002-02 1 CONTAINER in 1 CARTON (25208-002-02) > 250 mL in 1 CONTAINER

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 25MG BASE/500ML (EQ 0.05MG BASE/ML)
Approval Date:May 14, 1998TE:RLD:No
Patent:5,733,919Patent Expiration:Oct 23, 2016Product Flag?Substance Flag?Delist Request?
Patent:5,965,581Patent Expiration:Oct 23, 2016Product Flag?Substance Flag?Delist Request?
Patent:5,972,967Patent Expiration:Oct 23, 2016Product Flag?Substance Flag?Delist Request?

Expired Orange Book Patents for NDA: 020913

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-003Apr 20, 20005,733,919► subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-002May 17, 20025,292,756► subscribe
Medicure
AGGRASTAT
tirofiban hydrochloride
INJECTABLE;INJECTION020913-003Apr 20, 20005,965,581► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc